Zurueck zur Suche

Reporte zur Charge ELU140

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 GA 2

VAERS 923983

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ELU140

moderat
Staat
TX
Alter
32,0
Geschlecht
F
Eingang
13.01.2021
Impfdatum
04.01.2021
Beginn
04.01.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Back pain Body temperature Erythema Heart rate increased Joint swelling Pyrexia Fatigue Gingival pain Heart rate Hyperhidrosis Inappropriate schedule of product administration Lymphadenopathy Migraine Myalgia Skin burning sensation Tachycardia

Symptomtext

tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
Test Date: 20210104; Test Name: Fever; Result Unstructured Data: Test Result:above 101; Test Date: 20210104; Test Name: tachycardia; Result Unstructured Data: Test Result:140 bpm; Comments: 140 bpm
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic reaction to wasp sting; Bee sting hypersensitivity; Penicillin allergy
Andere Medikamente
NP THYROID; VITAMIN A [COLECALCIFEROL;RETINOL]; VITAMIN D [COLECALCIFEROL]; VITAMIN K [CALCIUM PHOSPHATE DIBASIC;PHYTOMENADIONE]; VITAMIN B12 [CYANOCOBALAMIN]
Allergien
-
Vorherige Impfungen
-

VAERS 923983

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ELU140

moderat
Staat
TX
Alter
32,0
Geschlecht
F
Eingang
13.01.2021
Impfdatum
04.01.2021
Beginn
04.01.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Back pain Body temperature Erythema Heart rate increased Joint swelling Pyrexia Fatigue Gingival pain Heart rate Hyperhidrosis Inappropriate schedule of product administration Lymphadenopathy Migraine Myalgia Skin burning sensation Tachycardia

Symptomtext

tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
Test Date: 20210104; Test Name: Fever; Result Unstructured Data: Test Result:above 101; Test Date: 20210104; Test Name: tachycardia; Result Unstructured Data: Test Result:140 bpm; Comments: 140 bpm
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic reaction to wasp sting; Bee sting hypersensitivity; Penicillin allergy
Andere Medikamente
NP THYROID; VITAMIN A [COLECALCIFEROL;RETINOL]; VITAMIN D [COLECALCIFEROL]; VITAMIN K [CALCIUM PHOSPHATE DIBASIC;PHYTOMENADIONE]; VITAMIN B12 [CYANOCOBALAMIN]
Allergien
-
Vorherige Impfungen
-

VAERS 922854

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ELU140

mild
Staat
GA
Alter
54,0
Geschlecht
F
Eingang
12.01.2021
Impfdatum
21.12.2020
Beginn
29.12.2020
Tage bis Beginn
8,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Feeling abnormal Gait disturbance Head discomfort Headache Nausea Vertigo Vomiting Loss of personal independence in daily activities Retching Visual impairment

Symptomtext

severe dizziness; nausea; vomiting; headache; Vertigo type symptoms; This is a spontaneous report from a contactable nurse. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELU140), via an unspecified route of administration on 21Dec2020 11:00 in right arm at single dose for COVID-19 immunization. Medical history included vertigo from 2015 to an unknown date. There were no concomitant medications. On 29Dec2020 19:00, one week after vaccination, the patient experienced severe dizziness, nausea, vomiting and headache that continues and seemed to be severe vertigo type symptoms. No treatment was given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in a Public Health Clinic/Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered. The events was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Vertigo
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 922854

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ELU140

mild
Staat
GA
Alter
54,0
Geschlecht
F
Eingang
12.01.2021
Impfdatum
21.12.2020
Beginn
29.12.2020
Tage bis Beginn
8,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Feeling abnormal Gait disturbance Head discomfort Headache Nausea Vertigo Vomiting Loss of personal independence in daily activities Retching Visual impairment

Symptomtext

severe dizziness; nausea; vomiting; headache; Vertigo type symptoms; This is a spontaneous report from a contactable nurse. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELU140), via an unspecified route of administration on 21Dec2020 11:00 in right arm at single dose for COVID-19 immunization. Medical history included vertigo from 2015 to an unknown date. There were no concomitant medications. On 29Dec2020 19:00, one week after vaccination, the patient experienced severe dizziness, nausea, vomiting and headache that continues and seemed to be severe vertigo type symptoms. No treatment was given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in a Public Health Clinic/Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered. The events was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Vertigo
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-